Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedMar 22, 2023Alprazolam TabletsCGMP Deviations: Potential risk of Cross ContaminationBreckenridge Pharmaceutical, Inc · D-0461-2023Class IITerminatedMar 22, 2023Alprazolam TabletsCGMP Deviations: Potential risk of Cross ContaminationBreckenridge Pharmaceutical, Inc · D-0460-2023Class IITerminatedMar 22, 2023Alprazolam TabletsCGMP Deviations: Potential risk of Cross ContaminationBreckenridge Pharmaceutical, Inc · D-0459-2023Class IITerminatedMar 22, 2023Alprazolam TabletsCGMP Deviations: Potential risk of Cross ContaminationBreckenridge Pharmaceutical, Inc · D-0458-2023Class IIOngoingMar 15, 2023Purely Soothing MSM Nasal SprayCGMP DeviationsPharmedica USA, LLC · D-0457-2023Class IOngoingMar 15, 2023Purely Soothing 15% MSM DropsNon-SterilityPharmedica USA, LLC · D-0456-2023Class IOngoingMar 15, 2023Snowy Range Blue Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-Sterile SolutionChemical Contamination: FDA analysis found the product to contain methanol, acetaldehyde, and acetal above the limits.Nanomaterials Discovery Corporation · D-0455-2023Class IIITerminatedMar 15, 2023DIBUCAINE 1% HEMORRHOIDAL OINTMENTLabeling: Incorrect or Missing Lot and/or Exp DateAkron Pharma, Inc. · D-0454-2023Class IITerminatedMar 15, 2023Unguentine Original Maximum Strength Pain Relieving/Antiseptic OintmentCGMP DEVIATIONSEcometics, Inc. · D-0452-2023Class IITerminatedMar 15, 2023Activator ConcentrateCGMP DEVIATIONSEcometics, Inc. · D-0451-2023Class IITerminatedMar 15, 2023Nose Better GelCGMP DEVIATIONSEcometics, Inc. · D-0450-2023Class IITerminatedMar 15, 2023Soltice Quick-RUBCGMP DEVIATIONSEcometics, Inc. · D-0449-2023Class IITerminatedMar 15, 2023Unguentine Original Ointment for BurnsCGMP DEVIATIONSEcometics, Inc. · D-0448-2023Class IITerminatedMar 15, 2023Vencedor medicated balmCGMP DEVIATIONSEcometics, Inc. · D-0447-2023Class IITerminatedMar 15, 2023Alcolado RelampagoCGMP DEVIATIONSEcometics, Inc. · D-0446-2023Class IITerminatedMar 15, 2023Phenylephrine HCl 20 mgCGMP DEVIATIONSDenver Solutions, LLC DBA Leiters Health · D-0445-2023Class IITerminatedMar 15, 2023Phenylephrine HCl 40 mgCGMP DEVIATIONSDenver Solutions, LLC DBA Leiters Health · D-0444-2023Class IITerminatedMar 15, 2023Phenylephrine HCl 1mg per 10mLCGMP DEVIATIONSDenver Solutions, LLC DBA Leiters Health · D-0443-2023Class IITerminatedMar 15, 2023Phenylephrine HCl 0.5 mg per 5 mLCGMP DEVIATIONSDenver Solutions, LLC DBA Leiters Health · D-0442-2023Class IITerminatedMar 15, 2023Metformin hydrochloride Extended-Release TabletsCGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.Teva Pharmaceuticals USA Inc · D-0441-2023Class IIOngoingMar 15, 2023NaturalCareCGMP Deviations: Raw material recalled by repackager, due to discoloration.Nutraceutical Corporation · D-0440-2023Class IIOngoingMar 15, 2023NaturalCare bioAllersCGMP Deviations: Raw material recalled by repackager, due to discoloration.Nutraceutical Corporation · D-0439-2023Class IIOngoingMar 15, 2023NatraBioCGMP Deviations: Raw material recalled by repackager, due to discoloration.Nutraceutical Corporation · D-0438-2023Class IIOngoingMar 15, 2023NaturalCare bioAllersCGMP Deviations: Raw material recalled by repackager, due to discoloration.Nutraceutical Corporation · D-0437-2023Class IITerminatedMar 15, 2023Verapamil Hydrochloride Extended-Release TabletsFailed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.Amerisource Health Services LLC · D-0436-2023Class IITerminatedMar 15, 2023Heparin Sodium InjectionLabeling: Not elsewhere classifiedSagent Pharmaceuticals Inc · D-0435-2023Class IITerminatedMar 15, 2023Heparin SodiumSubpotent Drug: low Anti-Factor IIa potency.B. Braun Medical Inc · D-0434-2023Class IICompletedMar 15, 2023Brimonidine Tartrate Ophthalmic Solution 0.15%Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap...Apotex Corp. · D-0433-2023Class ITerminatedMar 8, 2023PrimeZEN Black 6000 capsuleMarketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products...Volt Candy Wholesale Club · D-0453-2023Class IITerminatedMar 8, 2023Carbidopa and Levodopa TabletsPackaging defect: observed packaging defect, blister packaging inadequately sealed.The Harvard Drug Group · D-0432-2023Class IITerminatedMar 8, 2023rOPINIRole Tablets USP 5 mg*CGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0431-2023Class IITerminatedMar 8, 2023rOPINIRole Tablets USP 4 mg*CGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0430-2023Class IITerminatedMar 8, 2023rOPINIRole Tablets USP 3 mg*CGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0429-2023Class IITerminatedMar 8, 2023rOPINIRole Tablets USP 2 mg*CGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0428-2023Class IITerminatedMar 8, 2023rOPINIRole Tablets USP 1 mg*CGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0427-2023Class IITerminatedMar 8, 2023rOPINIRole Tablets USP 0.5 mg*CGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0426-2023Class IITerminatedMar 8, 2023rOPINIRole Tablets USP 0.25 mg*CGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0425-2023Class IITerminatedMar 8, 2023Pravastatin Sodium Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0424-2023Class IITerminatedMar 8, 2023Pravastatin Sodium Tablets USPCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0423-2023Class IITerminatedMar 8, 2023Pravastatin Sodium Tablets USP 20 mgCGMP Deviations: recalling drug products following an FDA inspection.Accord Healthcare, Inc. · D-0422-2023

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.